glp 1 thyroid 10 Surprising Facts About GLP-1/GIP Medications in Hypothyroid Patients GLP-1 Agonists: The Medical Revolution
Description
Retatrutide is not TGA-approved for therapeutic use in Australia
metformin 1000 mg BID led to conflicting results on hyperandrogenism
There is no Dr Elaine Tremblay listed on the Medical Board of Australia's Register of Practitioners and Google searches for her only turn up the fake Facebook page
This has never happened
GIP receptor activation in the brain may contribute to appetite regulation through mechanisms distinct from GLP-1 signaling, potentially explaining tirzepatide's superior weight loss compared to GLP-1 monoagonists
